This helps control blood sugar levels and, for many, aids in weight loss
Tirzepatide is a dual agonist at both GIP and GLP-1 receptors
The FDA has issued warnings about adverse events associated with compounded semaglutide, including hospitalizations from dosing errors, contaminated products, and preparations containing unapproved salt forms
While there may be some resistance to the conduction of clinical trials of pharmacological interventions in these clinical populations, the mechanistic profile of GLP-1RAs clearly suggests that these medications may play a role in the treatment of certain specific eating disorders, such as BED
The literature falls into four tiers
Plans are more likely to cover a GLP-1 for an FDA-approved use such as type 2 diabetes, and many employer plans still exclude weight-loss coverage entirely